Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             248 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormal oscillations in the slow pursuit eye movements of schizophrenic patients Ross, D.E.
 1989
 2 1-2 p. 91-
1 p.
 artikel
2 Abstracts of the second international congress on schizophrenia in San Diego, California, U.S.A. Nasrallah, Henry A.
 1989
 2 1-2 p. 3-
1 p.
 artikel
3 A comparison of developmental delay, childhood psychiatric morbidity and premorbid adjustment in patients with adult schizophrenia and affective disorder Foerster, A.
 1989
 2 1-2 p. 8-
1 p.
 artikel
4 A comparison of Huntington's disease and schizophrenia: matched tasks, cerebral blood flow, and neuropsychology Goldberg, TerryE.
 1989
 2 1-2 p. 136-
1 p.
 artikel
5 A computed tomographic study of brain density in schizophrenia Vita, Antonio
 1989
 2 1-2 p. 140-
1 p.
 artikel
6 Acute dystonic reactions during fixed-dose neuroleptic treatment Singh, Hardeep
 1989
 2 1-2 p. 247-
1 p.
 artikel
7 A.J. Prasad, N. Kumer & P. Kellner (Claybury Hospital, Woodford Bridge, Essex IG8 8BY) 1989
 2 1-2 p. 18-
1 p.
 artikel
8 Akathisia: clinical phenomenology and relationship to tardive dyskinesia Kahn, E.Michael
 1989
 2 1-2 p. 243-
1 p.
 artikel
9 Alprazolam-neuroleptic treatment in schizophrenia Wolkowitz, OwenM.
 1989
 2 1-2 p. 215-
1 p.
 artikel
10 Analysis of brain gene expression in schizophrenia by molecular cloning techniques Perrett, C.W.
 1989
 2 1-2 p. 46-
1 p.
 artikel
11 A new approach to the neurobiology of schizophrenia using monoclonal antibodies Honer, W.G.
 1989
 2 1-2 p. 101-
1 p.
 artikel
12 Anomalies in topography of P300 response to target and novel stimuli in schizophrenic patients Merrin, EdwardL.
 1989
 2 1-2 p. 85-
1 p.
 artikel
13 Anterior coronal brain and ventricular measures in male schizophrenics using MRI Olson, StephenC.
 1989
 2 1-2 p. 126-
1 p.
 artikel
14 Antibrain and generalized autoimmunity in a subgroup of RDC schizophrenics Ganguli, R.
 1989
 2 1-2 p. 150-
1 p.
 artikel
15 Anticipatory saccades, macro-square wave jerks, and schizotypy in first- degree relatives of probands with schizophrenia Clementz, BrettA.
 1989
 2 1-2 p. 89-
1 p.
 artikel
16 Anticonvulsants as adjuncts of neuroleptic treatment in schizophrenic psychoses Dose, M.
 1989
 2 1-2 p. 202-
1 p.
 artikel
17 Antipsychotic drugs increase synthesis of a 30 kda polypeptide: a stereospecific, therapeutically relevant effect in human lymphocytes Nimgaonkar, V.L.
 1989
 2 1-2 p. 170-
1 p.
 artikel
18 A parameter of the dark-adapted electroretinogram correlates with ratings of positive symptoms and abnormal involuntary movements in chronic schizophrenic subjects Straw, G.M.
 1989
 2 1-2 p. 96-
1 p.
 artikel
19 A pilot study of subcortical dementia in schizophrenia Pantelis, Chris
 1989
 2 1-2 p. 69-
1 p.
 artikel
20 Apomorphine-induced yawning in the investigation of dopaminergic function in man Lal, S.
 1989
 2 1-2 p. 159-
1 p.
 artikel
21 A preliminary analysis of symptoms observed in familial vs. non-familial schizophrenia in the provincial sample of the Danish-American adoption studies Ingraham, LoringJ.
 1989
 2 1-2 p. 45-
1 p.
 artikel
22 A progress report: the finish adoptive family study of schizophrenia Tienari, Pekka
 1989
 2 1-2 p. 47-
1 p.
 artikel
23 A re-appraisal of positron emission tomography findings of hypofrontal glucose utilization in schizophrenics Lewine, RichardR.J.
 1989
 2 1-2 p. 111-
1 p.
 artikel
24 Are schizophrenic deficits in signal detection during vigilance and span of apprehension vulnerability or episode indicators? Nuechterlein, KeithH.
 1989
 2 1-2 p. 68-
1 p.
 artikel
25 A second look at left temporal memory deficit in schizophrenia: toward a functionalist interpretation and paradigm shift Wood, FrankB.
 1989
 2 1-2 p. 141-
1 p.
 artikel
26 Assessment and effects of attentional deficits in schizophrenics Bowen, Linda
 1989
 2 1-2 p. 56-
1 p.
 artikel
27 Assessment of presynaptic indicators of dopaminergic neurons in post mortem brain tissue in schizophrenia Czudek, Carole
 1989
 2 1-2 p. 98-
1 p.
 artikel
28 Associations between plasma amino acid ratios and family history of psychopathology in schizophrenics Crowner, M.L.
 1989
 2 1-2 p. 38-
1 p.
 artikel
29 Astrocytosis of the “extended amygdala” in schizophrenia Casanova, MF
 1989
 2 1-2 p. 97-
1 p.
 artikel
30 A study using gadopenetetate dimeglumine enhanced MRI scans in schizophrenia Szymanski, S.
 1989
 2 1-2 p. 131-
1 p.
 artikel
31 A trial of micelamide in schizophrenia Berger, S.Paul
 1989
 2 1-2 p. 194-
1 p.
 artikel
32 Attention and schizophrenia Cornblatt, BarbaraA.
 1989
 2 1-2 p. 58-
1 p.
 artikel
33 A twin study of criminal behaviour in schizophrenia Reveley, Adrianne
 1989
 2 1-2 p. 20-
1 p.
 artikel
34 A virus-mediated alpha interferon immunopathological theory of schizophrenia Waltrip II, RoyceW.
 1989
 2 1-2 p. 177-
1 p.
 artikel
35 Basal ganglia mineralization in schizophrenia Prasad, CM
 1989
 2 1-2 p. 139-
1 p.
 artikel
36 Baseline demographic characteristics, treatment history, and presenting psychopathology as predictors of early course Hargreaves, W.A.
 1989
 2 1-2 p. 12-
1 p.
 artikel
37 Beta blockers in akathisia updated: toward understanding the effect Adler, L
 1989
 2 1-2 p. 241-
1 p.
 artikel
38 Biochemical effects of clozapine in schizophrenia Lieberman, Jeffrey
 1989
 2 1-2 p. 164-
1 p.
 artikel
39 Blood polyamine in schizophrenia Das, I.
 1989
 2 1-2 p. 146-
1 p.
 artikel
40 BMY 14802: a potential antipsychotic with affinity for sigma sites but not dopamine or PCP sites Taylor, DuncanP.
 1989
 2 1-2 p. 192-
1 p.
 artikel
41 Brain density in schizophrenia Daniel, DG
 1989
 2 1-2 p. 135-
1 p.
 artikel
42 Brain morphology at the onset of schizophrenia Gupta, S.M.
 1989
 2 1-2 p. 120-
1 p.
 artikel
43 Brain morphology, dopamine and outcome in first episode schizophrenia Lieberman, Jeffrey
 1989
 2 1-2 p. 163-
1 p.
 artikel
44 Brain morphology in schizophreniform disorder and in schizophrenic spectrum personality disorders Cazzullo, CarloLorenzo
 1989
 2 1-2 p. 25-
1 p.
 artikel
45 Brief intermittent neuroleptic prophylaxis for stable schizophrenic outpatients: two year outcome Jolley, A.G.
 1989
 2 1-2 p. 208-
1 p.
 artikel
46 Brief neuroleptic treatment causes lasting changes in extrapyramidal syndromes and sedation in monkeys Casey, DanielE.
 1989
 2 1-2 p. 234-
1 p.
 artikel
47 Can communication deviance be measured in an interactional setting? Velligan, DawnI.
 1989
 2 1-2 p. 231-
1 p.
 artikel
48 Candidate neuronal mechanisms for abnormal sensory gating in schizophrenia Freedman, Robert
 1989
 2 1-2 p. 82-
1 p.
 artikel
49 Carbamazepine treatment of schizophrenia Carpenter Jr., WilliamT.
 1989
 2 1-2 p. 197-
1 p.
 artikel
50 Cerebrospinal fluid met5-enkephalin-arg6-gly7-leu8 immunoreactive peptides: differential effect of haloperidol compared to clozapine Iadarola, M.J.
 1989
 2 1-2 p. 152-
1 p.
 artikel
51 Cerebrospinal fluid proteins in schizophrenia: functional markers for blood-brain barrier permeability and central nervous system immunoglobulin production Kirch, DarrellG.
 1989
 2 1-2 p. 156-
1 p.
 artikel
52 Changes in auditory steady-state responses during neuroleptic treatment Makeig, Scott
 1989
 2 1-2 p. 84-
1 p.
 artikel
53 Characterization of 3H-GBR 12935 binding to the dopamine transporter in human frontal cortex and its relevance to schizophrenia Hitri, Ana
 1989
 2 1-2 p. 100-
1 p.
 artikel
54 Chemically-identified neural circuitry of the primate prefrontal cortex Lewis, DavidA.
 1989
 2 1-2 p. 162-
1 p.
 artikel
55 Clinical and biological correlates in chronic schizophrenia Obiols, J.E.
 1989
 2 1-2 p. 34-
1 p.
 artikel
56 Clinical and neuropsychologic characteristics of schizophrenics showing impairment on the luria-nebraska neuropsychological battery Faustman, WilliamO.
 1989
 2 1-2 p. 61-
1 p.
 artikel
57 Clinical correlates of elevated plasma hva in psychotic disorders of recent onset Bowers Jr., MalcolmB.
 1989
 2 1-2 p. 143-
1 p.
 artikel
58 Clinical correlates of prolactin concentration in outpatient schizophrenics Kirkpatrick, Brian
 1989
 2 1-2 p. 157-
1 p.
 artikel
59 Clozapine inhibits [3H]MK-801 binding to the glutamate receptor — ion channel complex Janowsky, Aaron
 1989
 2 1-2 p. 189-
1 p.
 artikel
60 Cognitive function in schizophrenia followed prospectively over 5 years: Do neuropsychological deficits reflect active or static disease? Waddington, JohnL.
 1989
 2 1-2 p. 75-
1 p.
 artikel
61 Cognitive impairment and tardive dyskinesia Gold, James
 1989
 2 1-2 p. 236-
1 p.
 artikel
62 Communication deviance in parents of schizophrenic and manic patients Miklowitz, DavidJ.
 1989
 2 1-2 p. 229-
1 p.
 artikel
63 Community adjustment of clozapine responders: A one year follow-up Davies, MarilynA.
 1989
 2 1-2 p. 201-
1 p.
 artikel
64 Computerized studies of mouth movement abnormalities which gradually develop in rats following chronic neuroleptics: implications for tardive dyskinesia Ellison, GaylordD.
 1989
 2 1-2 p. 235-
1 p.
 artikel
65 Concordance of familial nonarteriosclerotic mineralization of the basal ganglia and schizophrenia in two generations: a case report Casanova, MF
 1989
 2 1-2 p. 134-
1 p.
 artikel
66 Criteria for improvement in schizophrenia research Manchanda, Rahul
 1989
 2 1-2 p. 210-
1 p.
 artikel
67 CSF concentrations of CRF and ACTH in schizophrenia: Relationships to CSF catecholamine metabolites Risch, S.Craig
 1989
 2 1-2 p. 173-
1 p.
 artikel
68 CT morphology and short term outcome in schizophrenia Ninan, PhilipT.
 1989
 2 1-2 p. 137-
1 p.
 artikel
69 D2 dopamine receptors increased in psychotic, but not non-psychotic affective disorder Pearlson, GD
 1989
 2 1-2 p. 113-
1 p.
 artikel
70 D2 dopamine receptors in drug naive schizophrenics: update on 20 subjects Tune, LE
 1989
 2 1-2 p. 114-
1 p.
 artikel
71 Depressive symptomatology, negative symptoms and extrapyramidal symptoms (EPMS) in acute treatment response and short term outcome Glick, IraD.
 1989
 2 1-2 p. 204-
1 p.
 artikel
72 Developmental differences in response to haloperidol: Regional dopamine turnover Teicher, MartinH.
 1989
 2 1-2 p. 175-
1 p.
 artikel
73 Dimensions of the brief psychiatric rating scales in schizophrenic samples with increasing psychopathology Coyne, Lolafaye
 1989
 2 1-2 p. 199-
1 p.
 artikel
74 Disruption of prepulse inhibition of acoustic startile in rats by phencyclidine and MK801 Geyer, MarkA.
 1989
 2 1-2 p. 186-
1 p.
 artikel
75 Dopamine D1 antagonists do not produce extrapyramidal side effects (EPS) in cebus monkeys Coffin, V.L.
 1989
 2 1-2 p. 180-
1 p.
 artikel
76 DSM-III-R schizotypal personality features and disorder in offspring, siblings and parents of schizophrenic disorder, affective disorder, and normal control parent probands Squires-Wheeler, Elizabeth
 1989
 2 1-2 p. 36-
1 p.
 artikel
77 Editorial Board 1989
 2 1-2 p. IFC-
1 p.
 artikel
78 EEG and medication response in schizophrenia Kahn, E.Michael
 1989
 2 1-2 p. 76-
1 p.
 artikel
79 Effects of the D-1 agonist SKF-38393, combined with haloperidol, in schizophrenic patients: A preliminary report Davidson, Michael
 1989
 2 1-2 p. 200-
1 p.
 artikel
80 Electrodermal measures in schizophrenia: Episode or vulnerability indicators? Dawson, MichaelE.
 1989
 2 1-2 p. 94-
1 p.
 artikel
81 Electroencephalographic sleep abnormalities in schizophrenia: Relationship to positive/negative symptoms and ventricular enlargement Tandon, Rajiv
 1989
 2 1-2 p. 80-
1 p.
 artikel
82 Electrophysiological and behavioral signs of attentional disturbance in schizophrenics and their siblings Steinhauer, StuartR.
 1989
 2 1-2 p. 88-
1 p.
 artikel
83 Elevated values of frontal white matter in schizophrenia Harvey, Ian
 1989
 2 1-2 p. 121-
1 p.
 artikel
84 Epidosic dyscontrol and personality dimensions among schizophrenic outpatients Hanlon, ThomasE.
 1989
 2 1-2 p. 26-
1 p.
 artikel
85 Estimation of fluid intake in polydipsic schizophrenics Koczapski, A.B.
 1989
 2 1-2 p. 158-
1 p.
 artikel
86 Everyday events and the temporal course of daily fluctuations of psychotic symptoms Aebi, Elisabeth
 1989
 2 1-2 p. 217-
1 p.
 artikel
87 Eye movement abnormalities in schizophrenia Sweeney, John
 1989
 2 1-2 p. 92-
1 p.
 artikel
88 Failure of subjective complaints to respond to haloperidol in acute schizophrenia Bitter, Istvan
 1989
 2 1-2 p. 195-
1 p.
 artikel
89 Family factors identifying schizophrenic patients at risk of relapse Lebell, MalcaB.
 1989
 2 1-2 p. 227-
1 p.
 artikel
90 Family history of psychosis, obstetric complications, premorbid functioning, and CT scan findings in schizophrenia patients Reddy, Ravinder
 1989
 2 1-2 p. 19-
1 p.
 artikel
91 Fluctuating dermatoglyphic asymmetry and its association with positive and negative symptoms in schizophrenia Ricker, JeffryP.
 1989
 2 1-2 p. 73-
1 p.
 artikel
92 GABA hypothesis of tardive dyskinesia: clinical neurochemistry and neurophysiology Lahti, Adrienne
 1989
 2 1-2 p. 237-
1 p.
 artikel
93 GABA hypothesis of tardive dyskinesia: pharmacology Thaker, Gunvant
 1989
 2 1-2 p. 239-
1 p.
 artikel
94 Gamma function describes post-natal changes in brain metabolic rate, synaptic density, and delta wave amplitude: implications for schizophrenia research Feinberg, I.
 1989
 2 1-2 p. 149-
1 p.
 artikel
95 Gender and schizophrenia: identification of subtypes of the illness Goldstein, Jill M.
 1989
 2 1-2 p. 9-
1 p.
 artikel
96 Gender, psychopathology and corpus callosal shape Gulley, LawrenceR.
 1989
 2 1-2 p. 119-
1 p.
 artikel
97 Genetic analysis of schizophrenia using both affection status and a psychometric indicator of liability: implications for high-risk research Moldin, StevenO.
 1989
 2 1-2 p. 50-
1 p.
 artikel
98 Genetic and perinatal determinants of structural brain deficits in schizophrenia Cannon, TyroneD.
 1989
 2 1-2 p. 5-
1 p.
 artikel
99 Genetic counseling of psychotic disorders Lamparski, DanutaM.
 1989
 2 1-2 p. 226-
1 p.
 artikel
100 Genetic heterogeneity in schizophrenia: contributions from a North Swedish kindred Kennedy, JamesL.
 1989
 2 1-2 p. 43-
1 p.
 artikel
101 Glutamate receptors and effector mechanisms in postmortem temporal lobe in schizophrenia Kerwin, RobertW.
 1989
 2 1-2 p. 104-
1 p.
 artikel
102 Glycine agonists antagonize phencyclidine-induced stereotyped behavior and ataxia in rats Contreras, PatriciaC.
 1989
 2 1-2 p. 181-
1 p.
 artikel
103 Growth hormone response to growth hormone releasing factor in schizophrenia Mayerhoff, D.
 1989
 2 1-2 p. 166-
1 p.
 artikel
104 Heterogeneity of schizophrenia: prelininary evidence for multiple genetic loci Aschauer, Harald
 1989
 2 1-2 p. 39-
1 p.
 artikel
105 Hospitalization effect on acute exacerbation of schizophrenia Cohen, Seth
 1989
 2 1-2 p. 220-
1 p.
 artikel
106 How old is the lesion presenting as schizophrenia? Relevance to the laterality question Bracha, H.Stefan
 1989
 2 1-2 p. 144-
1 p.
 artikel
107 Human and animal models of information processing in schizophrenia Braff, DavidL.
 1989
 2 1-2 p. 145-
1 p.
 artikel
108 Hypoplasia of the cerebellar vermal lobules VI and VII on MRI scans in schizophrenia is associated with perinatal brain insult Nasrallah, HenryA.
 1989
 2 1-2 p. 124-
1 p.
 artikel
109 Impaired binocular depth inversion as an indicator of psychosis Emrich, H.M.
 1989
 2 1-2 p. 60-
1 p.
 artikel
110 IMP spect cerebral perfusion studies in drug-naive schizophrenics Pahl, JJ
 1989
 2 1-2 p. 138-
1 p.
 artikel
111 Index of first authors 1989
 2 1-2 p. 248-250
3 p.
 artikel
112 Influence of patient-related variables on plasma levels of clozapine Barnas, Christian
 1989
 2 1-2 p. 193-
1 p.
 artikel
113 Interaction of antihistamines with the sigma and phencylidine (PCP) receptors Gray, NancyM.
 1989
 2 1-2 p. 187-
1 p.
 artikel
114 Interactions of excitatory amino acids with midbrain dopamine neurons Boksa, P.
 1989
 2 1-2 p. 142-
1 p.
 artikel
115 Intercorrelation of CSF HVA, 5-HIAA, and MHPG before and after probenecid administration Jibson, MichaelD.
 1989
 2 1-2 p. 155-
1 p.
 artikel
116 Interhemispheric transfer in schizophrenics, depressives, and normals with schizoid tendencies Raine, Adrian
 1989
 2 1-2 p. 71-
1 p.
 artikel
117 Intermittent medication in schizophrenia-2 years Herz, MarvinI.
 1989
 2 1-2 p. 206-
1 p.
 artikel
118 In vivo 31P nuclear magnetic resonance (NMR) spectroscope of the frontal lobe metabolism in neuroleptic naive first episode psychoses: preliminary studies Keshavan, M.S.
 1989
 2 1-2 p. 122-
1 p.
 artikel
119 Is there a deficit of limbic gaba neurons in schizophrenia? Reynolds, GavinP.
 1989
 2 1-2 p. 105-
1 p.
 artikel
120 Late onset non-affective endogenous psychosis. A report from India Jain, Sanjeev
 1989
 2 1-2 p. 30-
1 p.
 artikel
121 Lateralized deficits in covert shifts of visual attention in chronic and never-medicated schizophrenics compared to normal controls Potkin, StevenG.
 1989
 2 1-2 p. 95-
1 p.
 artikel
122 Life events and schizophrenic relapse during medical withdrawal Ventura, Joseph
 1989
 2 1-2 p. 232-
1 p.
 artikel
123 Longitudinal evaluation of older schizophrenics Hoffman, WilliamF.
 1989
 2 1-2 p. 29-
1 p.
 artikel
124 Long-term clinical profile of schizophreniform disorder Heinssen, RobertK.
 1989
 2 1-2 p. 28-
1 p.
 artikel
125 Long term community care through an assertive continuous treatment team Test, MaryAnn
 1989
 2 1-2 p. 230-
1 p.
 artikel
126 Long-term outcome of DSM-III schizophrenia Harding, CourtenayM.
 1989
 2 1-2 p. 27-
1 p.
 artikel
127 Low dose pharmacotherapy and skills training Marder, StephenR.
 1989
 2 1-2 p. 211-
1 p.
 artikel
128 Magnetic resonance imaging in schizophrenia Pandurangi, AnandK.
 1989
 2 1-2 p. 127-
1 p.
 artikel
129 Magnetic resonance imaging of the limbic system Lim, KelvinO.
 1989
 2 1-2 p. 123-
1 p.
 artikel
130 Magnetic resonance imaging studies of tardive dyskinesia in schizophrenic patients Bartzokis, George
 1989
 2 1-2 p. 116-
1 p.
 artikel
131 Mechanism of abnormal water balance in schizophrenia Goldman, MorrisB.
 1989
 2 1-2 p. 151-
1 p.
 artikel
132 Medication enhances the development of automated information processing in schizophrenia Harvey, PhilipD.
 1989
 2 1-2 p. 66-
1 p.
 artikel
133 Mesolimbic and striatal dopamine D2 receptors differ in the time course of neuroleptic-induced upregulation Bellows, ElisabethP.
 1989
 2 1-2 p. 179-
1 p.
 artikel
134 Methodological issues in PET scan evaluation of dopamine supersensitivity in tardive dyskinesia Losonczy, MiklosF.
 1989
 2 1-2 p. 112-
1 p.
 artikel
135 Monetary reinforcement reduces perseverative errors in patients with schizophrenia Summerfelt, AnnT.
 1989
 2 1-2 p. 74-
1 p.
 artikel
136 Monozygotic twins discordant for schizophrenia: preliminary perinatal, developmental, and neurological findings Fuller Torrey, E.
 1989
 2 1-2 p. 51-
1 p.
 artikel
137 Morphometric evidence for developmental disturbances in brains of some schizophrenics Falkai, P.
 1989
 2 1-2 p. 99-
1 p.
 artikel
138 Motor abnormalities improve in recovering schizophrenics Conley, RobertR.
 1989
 2 1-2 p. 244-
1 p.
 artikel
139 Multipoint linkage strategies in a Swedish kindred segregating schizophrenia Giuffra, LuisA.
 1989
 2 1-2 p. 41-
1 p.
 artikel
140 Multi-state model of PCP/NMDA receptor functioning: implications for schizophrenia research Javitt, DanielC.
 1989
 2 1-2 p. 154-
1 p.
 artikel
141 Neural implants in parkinson's disease: implications for schizophrenia Jones, Barry
 1989
 2 1-2 p. 102-
1 p.
 artikel
142 Neuroleptic-induced anhedonia: Recent studies Wise, RoyA.
 1989
 2 1-2 p. 178-
1 p.
 artikel
143 Neuroleptic noncompliance in schizophrenia Weiden, Peter
 1989
 2 1-2 p. 214-
1 p.
 artikel
144 Neuroleptics, tardive dyskinesia and reaction time in schizophrenia Spohn, HerbertE.
 1989
 2 1-2 p. 238-
1 p.
 artikel
145 Neuromagnetic assessment of temporal lobe function in schizophrenia Reite, Martin
 1989
 2 1-2 p. 81-
1 p.
 artikel
146 Neuron-target interactions analyzed with mutant <- > wild type mouse chimeras Vogel, MichaelW.
 1989
 2 1-2 p. 176-
1 p.
 artikel
147 Neuropsychological deficit in subtypes of schizophrenia Bornstein, R.A.
 1989
 2 1-2 p. 54-
1 p.
 artikel
148 Neuropsychological functioning in monozygotic twins discordant for schizophrenia Goldberg, TerryE.
 1989
 2 1-2 p. 63-
1 p.
 artikel
149 Neuropsychological impairments among siblings of schizophrenic probands Pogue-Geile, MichaelF.
 1989
 2 1-2 p. 70-
1 p.
 artikel
150 Neuropsychological impairments are greater in violent than nonviolent schizophrenics Jaeger, Judith
 1989
 2 1-2 p. 67-
1 p.
 artikel
151 Neuropsychological investigations of schizophrenia Gur, RubenC.
 1989
 2 1-2 p. 65-
1 p.
 artikel
152 Neuropsychological responses to stimulant challenge in schizophrenia Bilder, RobertM.
 1989
 2 1-2 p. 52-
1 p.
 artikel
153 Neuropsychology of the development of cognitive and emotional symptoms of schizophrenic patients using the connectivity model Reischies, F.M.
 1989
 2 1-2 p. 72-
1 p.
 artikel
154 Neurotransmitter systems function in schizophrenia/psychosis Maas, JamesW.
 1989
 2 1-2 p. 165-
1 p.
 artikel
155 Non-classical neuroleptic-like properties of partial dopamine agonists Coward, D.M.
 1989
 2 1-2 p. 183-
1 p.
 artikel
156 Paraphrenia revisited: from kraepelin to DSM-III-R and beyond Jeste, DilipV.
 1989
 2 1-2 p. 32-
1 p.
 artikel
157 Patterns of neuroleptic usage in continuously hospitalized schizophrenic patients: Evidence for development of drug tolerance Sramek, John
 1989
 2 1-2 p. 213-
1 p.
 artikel
158 Perceptual asymmetry for happy-sad chimeric faces: differences between schizophrenia, affected disorder and normal variations in mood David, AnthonyS.
 1989
 2 1-2 p. 59-
1 p.
 artikel
159 Perinatal complications are associated with poor premorbid function in schizophrenia Olson, StephenC.
 1989
 2 1-2 p. 16-
1 p.
 artikel
160 Persistence of antipsychotic drug effects and tissue levels Cohen, BruceM.
 1989
 2 1-2 p. 198-
1 p.
 artikel
161 Pharmacological approaches towards the development of atypical antipsychotics Coward, D.M.
 1989
 2 1-2 p. 182-
1 p.
 artikel
162 Pharmacologic challenge in akathisia variants Duncan, Erica
 1989
 2 1-2 p. 242-
1 p.
 artikel
163 Phencyclidine and σ-psychotomimetic drugs activate mesocorticolimbic dopamine neurons through the nonhaloperidol sensitive phencyclidine binding site. French, EdwardD.
 1989
 2 1-2 p. 184-
1 p.
 artikel
164 Phenylalaline as a differentiator of schizophrenic subgroups Richardson, M.A.
 1989
 2 1-2 p. 172-
1 p.
 artikel
165 Photic driving alpha EEG spectrum abnormalities in schizophrenic patients compared to controls Potkin, StevenG.
 1989
 2 1-2 p. 78-
1 p.
 artikel
166 Plasma HVA in schizophreniform disorder and chronic schizophrenia Muscettola, G.
 1989
 2 1-2 p. 169-
1 p.
 artikel
167 Plasma levels of Fluphenazine and prolactin in maintenance treatment of schizophrenia Yadalam, KashinathG.
 1989
 2 1-2 p. 216-
1 p.
 artikel
168 31P magnetic resonance spectroscopy of the left temporal lobe in schizophrenia: procedures and preliminary results O'Callaghan, E.
 1989
 2 1-2 p. 125-
1 p.
 artikel
169 Polydipsia, hyponatremia, and smoking in schizophrenia polydipsia, hyponatremia, and continine levels in schizophrenia Lawson, W.
 1989
 2 1-2 p. 160-
1 p.
 artikel
170 Post-mortem neurochemical studies of tardive dyskinesia Reynolds, GavinP.
 1989
 2 1-2 p. 106-
1 p.
 artikel
171 Potential applications of positron emission probes in the study of schizophrenia Jeffries, K.J.
 1989
 2 1-2 p. 110-
1 p.
 artikel
172 Prefrontal cortical blood flow in monozygotic twins concordant and discordant for schizophrenia Berman, KarenFaith
 1989
 2 1-2 p. 132-
1 p.
 artikel
173 Preliminary linkage analysis of schizophrenia in Canadian pedigrees to a candidate region on chromosome 5 Bassett, AnneS.
 1989
 2 1-2 p. 40-
1 p.
 artikel
174 Prenatal influenza infection as an etiological factor in schizophrenia Barr, ChristopherE.
 1989
 2 1-2 p. 4-
1 p.
 artikel
175 Presynaptic d2 receptor selectivity of roxindole. possible indirect effects of postsynaptic striatal cholinergic neurons Seyfried, ChristophA.
 1989
 2 1-2 p. 246-
1 p.
 artikel
176 Psychopathology in schizophrenics and their families Taylor, MichaelAlan
 1989
 2 1-2 p. 37-
1 p.
 artikel
177 Psychosis and climate: a discussion of some findings arising out of the world health organization's studies on schizophrenia Gupta, Sunjai
 1989
 2 1-2 p. 10-
1 p.
 artikel
178 Quantitative dopamine & serotonin receptor autoradiographic differences between clozapine & haloperidol O'Dell, StevenJ.
 1989
 2 1-2 p. 190-
1 p.
 artikel
179 Quantitative magnetic resonance imaging in twin pairs discordant for schizophrenia Suddath, R.L.
 1989
 2 1-2 p. 129-
1 p.
 artikel
180 Reciprocal interaction patterns in the families of recent onset schizophrenics related to short term course of the disorder Goldstein, MichaelJ.
 1989
 2 1-2 p. 222-
1 p.
 artikel
181 Recognition memory for words versus faces in syndromes of schizophrenia Gruzelier, John
 1989
 2 1-2 p. 64-
1 p.
 artikel
182 Recognition of relapse in schizophrenic outpatients Mance, Rosalind
 1989
 2 1-2 p. 209-
1 p.
 artikel
183 Relationship of CT scan findings, amine metabolites and clinical state in schizophrenic and control subjects Seleshi, Ermias
 1989
 2 1-2 p. 174-
1 p.
 artikel
184 Relevance of the dopamine D2 receptor blockade in clinical response to neuroleptic treatment in schizophrenic patients Hitri, Ana
 1989
 2 1-2 p. 207-
1 p.
 artikel
185 Religious delusions in a group of 50 chronic schizophrenic patients Meagher, JosephB.A.
 1989
 2 1-2 p. 228-
1 p.
 artikel
186 Restitutive system hypothesis of schizophrenia Friedhoff, A.J.
 1989
 2 1-2 p. 185-
1 p.
 artikel
187 Risk of schizophrenia in character disorders Fenton, WayneS.
 1989
 2 1-2 p. 7-
1 p.
 artikel
188 “Rounds”, a new time-sampling methodology for the quantitative assessment of negative symptoms: reliability and validity Boronow, JohnJ.
 1989
 2 1-2 p. 55-
1 p.
 artikel
189 Schizophrenia and chromosome 5: molecular mapping of the region containing a putative susceptibility locus Kaufman, CA
 1989
 2 1-2 p. 42-
1 p.
 artikel
190 Schizophrenia and substance abuse: preferences, predictors and psychopathology Dixon, Lisa
 1989
 2 1-2 p. 6-
1 p.
 artikel
191 Schizophrenia: Auditory P300 topographic analyses correlated with positive symptoms Shenton, MarthaE.
 1989
 2 1-2 p. 87-
1 p.
 artikel
192 Schizophrenia: Event-related potentials and cognition Holinger, DorothyP.
 1989
 2 1-2 p. 83-
1 p.
 artikel
193 Schizophrenia spectrum concepts and diagnosis McGlashan, ThomasH.
 1989
 2 1-2 p. 33-
1 p.
 artikel
194 Schizophrenic violence: Trait and state Krakowski, Menahem
 1989
 2 1-2 p. 225-
1 p.
 artikel
195 Self-induced water intoxication: the patients speak Millson, R.C.
 1989
 2 1-2 p. 167-
1 p.
 artikel
196 Sensory gating in schizophrenics and normal controls: Evidence for heterogeneity in schizophrenics Nagamoto, H.T.
 1989
 2 1-2 p. 86-
1 p.
 artikel
197 Sex differences in olfactory function in schizophrenia Kopala, Lili
 1989
 2 1-2 p. 13-
1 p.
 artikel
198 Sex differences in schizophrenia Haas, Gretchen
 1989
 2 1-2 p. 11-
1 p.
 artikel
199 Shape analysis of the middle cranial fossa of schizophrenic patients: A computerized tomographic study Casanova, MF
 1989
 2 1-2 p. 133-
1 p.
 artikel
200 Short-term clinical course following abrupt discontinuation of antipsychotic medication in patients with schizophrenia spectrum illness Flaum, Michael
 1989
 2 1-2 p. 203-
1 p.
 artikel
201 Sigma receptor system pharmacology: new tools to explore links with psychosis and novel antipsychotic drugs Stahl, StephenM.
 1989
 2 1-2 p. 191-
1 p.
 artikel
202 Simple schizophrenia-revisited Black, D.W.
 1989
 2 1-2 p. 24-
1 p.
 artikel
203 Skills training for chronic schizophrenic patients: evaluation of a therapy program on medication self-management Waldvogel, Doris
 1989
 2 1-2 p. 233-
1 p.
 artikel
204 Smaller MRI brain measures in familial vs sporadic schizophrenics: A replication Schwarzkopf, StevenB.
 1989
 2 1-2 p. 128-
1 p.
 artikel
205 Social climate of community-based psychiatric treatment facilities and adjustment among persons with schizophrenia Fox, JeanneC.
 1989
 2 1-2 p. 221-
1 p.
 artikel
206 Social competence in schizoaffective disorder, schizophrenia, and bipolar disorder Bellack, AllanS.
 1989
 2 1-2 p. 23-
1 p.
 artikel
207 Sociodemographic risk factors and psychopathologic precursors of the schizophrenia syndrome Tien, AllenY.
 1989
 2 1-2 p. 21-
1 p.
 artikel
208 Specificity of position emission tomographic findings in schizophrenia Buchsbaum, MonteS.
 1989
 2 1-2 p. 108-
1 p.
 artikel
209 Studies in integrated cognitive and social therapeutical interventions: Empirical results and theoretical implications Brenner, HansD.
 1989
 2 1-2 p. 219-
1 p.
 artikel
210 Study of schizophrenia spectrum illness (SSI) in a homogeneous population Goodman, AnnB.
 1989
 2 1-2 p. 44-
1 p.
 artikel
211 Task related changes of EEG spectral band power in patients with schizophrenia and normal controls Reeve, Alison
 1989
 2 1-2 p. 79-
1 p.
 artikel
212 Temporal lobe asymmetry in schizophrenics demonstrated by coronal MRI brain scans Coffman, JeffreyA.
 1989
 2 1-2 p. 117-
1 p.
 artikel
213 The analysis of verbal and nonverbal communication processes in families of schizophrenic and manic-depressive patients: Connections to “Communication deviance” (CD), “Affective style” (AS) and “Expressed Emotions” (EE) Altorfer, Andreas
 1989
 2 1-2 p. 218-
1 p.
 artikel
214 The blink-alpha circuit and gliosis in schizophrenia Karson, CraigN.
 1989
 2 1-2 p. 103-
1 p.
 artikel
215 The corpus callosum in schizophrenia and mania: a controlled MRI study Swayze II, VictorW.
 1989
 2 1-2 p. 130-
1 p.
 artikel
216 The deficit form of schizophrenia Buchanan, RobertW.
 1989
 2 1-2 p. 107-
1 p.
 artikel
217 The effect of chronic neuroleptic treatment on yawning behavior: is it relevant to schizophrenia? Diamond, BruceI.
 1989
 2 1-2 p. 147-
1 p.
 artikel
218 The effect of serotonergic agents on haloperidol-induced catalepsy Hicks, PaulB.
 1989
 2 1-2 p. 188-
1 p.
 artikel
219 The geography of schizophrenia in the United States Torrey, E.Fuller
 1989
 2 1-2 p. 22-
1 p.
 artikel
220 The influence of family management of patient stabilization Keith, SamuelJ.
 1989
 2 1-2 p. 224-
1 p.
 artikel
221 The machine measured characteristics of tardive dyskinesia Wirshing, WilliamC.
 1989
 2 1-2 p. 240-
1 p.
 artikel
222 The neuroanatomy of atypical handedness in schizophrenia Green, MichaelFoster
 1989
 2 1-2 p. 118-
1 p.
 artikel
223 The noradrenergic response to acute stress: correlates with clinical phenomenology, regional brain function, and neurophysiology in schizophrenia Mozley, David
 1989
 2 1-2 p. 168-
1 p.
 artikel
224 The pathophysiology of emotional blunting: implications for heterogeneity of schizophrenia Jampala, V.Chowdary
 1989
 2 1-2 p. 31-
1 p.
 artikel
225 The platelets polyphosphoinositide system in schizophrenia: pathological and pharmacological implications Essali, M.A.
 1989
 2 1-2 p. 148-
1 p.
 artikel
226 The “praecox feeling” in the diagnosis of schizophrenia; a survey of Manhattan psychiatrists Sagi, GyorgyA.
 1989
 2 1-2 p. 35-
1 p.
 artikel
227 Therapeutic efficacy of putative atypical antipsychotic agents Borison, RichardL.
 1989
 2 1-2 p. 196-
1 p.
 artikel
228 The relationship between season of birth and biological variables in schizophrenia Owen, M.J.
 1989
 2 1-2 p. 17-
1 p.
 artikel
229 The role of serotonin in the mechanism of action of antipsychotic drugs: Does 5-HT also have a role in the etiology of schizophrenia? Meltzer, HerbertY.
 1989
 2 1-2 p. 212-
1 p.
 artikel
230 The second international congress on schizophrenia research Schulz, S.C.
 1989
 2 1-2 p. 2-
1 p.
 artikel
231 The spectrum of effectiveness of cognitive and social interventions in schizophrenia: Results of single case studies Hodel, Betinna
 1989
 2 1-2 p. 223-
1 p.
 artikel
232 The stress response of dopaminergic systems after lesions of medial prefrontal cortex Jaskiw, GeorgeE.
 1989
 2 1-2 p. 153-
1 p.
 artikel
233 Three dimensional cortical surface morphometry and metabolism using registered magnetic resonance and position emission images Holcomb, HH
 1989
 2 1-2 p. 109-
1 p.
 artikel
234 Time course and clinical predictors of neuroleptic response in schizophrenia Harvey, PhilipD.
 1989
 2 1-2 p. 205-
1 p.
 artikel
235 Time segmented EEG potential mapping in medication free schizophrenic patients Merrin, EdwardL.
 1989
 2 1-2 p. 77-
1 p.
 artikel
236 Treatment course, clinical and neurobiological correlates of negative symptoms - towards an integraative model of schizophrenia Gaebel, Wolfgang
 1989
 2 1-2 p. 62-
1 p.
 artikel
237 Update on PET methods for D2 dopamine receptors in schizophrenia and bipolar disorder Wong, D.F.
 1989
 2 1-2 p. 115-
1 p.
 artikel
238 Uses of the MMPI in the St. Elizabeths Hospital discordant schizophrenic identical twin project Gottesman, IrvingI.
 1989
 2 1-2 p. 48-
1 p.
 artikel
239 Ventricular enlargement and dopaminergic-serotonergic balance in schizophrenia Lewine, Richard
 1989
 2 1-2 p. 161-
1 p.
 artikel
240 Viral antibodies in schizophrenia using the indirect elisa method Pelonero, AnthonyL.
 1989
 2 1-2 p. 171-
1 p.
 artikel
241 Vocal acoustic correlates of flat affect: Differences with other negative signs and with depression Alpert, Murray
 1989
 2 1-2 p. 93-
1 p.
 artikel
242 Vulnerability, personal resources and coping behaviour in schizophrenics and their relatives Böker, Wolfgang
 1989
 2 1-2 p. 53-
1 p.
 artikel
243 What can the neurodevelopmental model explain? Murray, Robin
 1989
 2 1-2 p. 15-
1 p.
 artikel
244 What is the nature of the eye movement dysfunctions found in schizophrenics? Levy, DeborahL.
 1989
 2 1-2 p. 90-
1 p.
 artikel
245 Who is an affected relative in genetic linkage studies of schizophrenia? Levinson, DouglasF.
 1989
 2 1-2 p. 49-
1 p.
 artikel
246 Wisconsin card sort performance in schizophrenia: A comparative and methodological analysis Butler, RobertW.
 1989
 2 1-2 p. 57-
1 p.
 artikel
247 Workshop in strategies for research and development in schizophrenia Lash, Leonard
 1989
 2 1-2 p. 245-
1 p.
 artikel
248 27 year followup of the Copenhagen high-risk for schizophrenia project: why did some of the high risk offspring become schizophrenic? Mednick, SarnoffA.
 1989
 2 1-2 p. 14-
1 p.
 artikel
                             248 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland